Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial)

NCT03932136 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT03932136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial)
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 14, 2019
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk syndrome of psychosis